- Home
- NMAI vs QTRX Comparison
NMAI vs QTRX Comparison
Compare NMAI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMAI
- QTRX
- Stock Information
- Founded
- NMAI 2021
- QTRX 2007
- Country
- NMAI United States
- QTRX United States
- Employees
- NMAI N/A
- QTRX N/A
- Industry
- NMAI Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- NMAI Finance
- QTRX Industrials
- Exchange
- NMAI Nasdaq
- QTRX Nasdaq
- Market Cap
- NMAI 427.2M
- QTRX 261.7M
- IPO Year
- NMAI N/A
- QTRX 2017
- Fundamental
- Price
- NMAI $12.92
- QTRX $5.28
- Analyst Decision
- NMAI
- QTRX Hold
- Analyst Count
- NMAI 0
- QTRX 4
- Target Price
- NMAI N/A
- QTRX $11.75
- AVG Volume (30 Days)
- NMAI 74.8K
- QTRX 661.4K
- Earning Date
- NMAI 01-01-0001
- QTRX 11-11-2025
- Dividend Yield
- NMAI 13.14%
- QTRX N/A
- EPS Growth
- NMAI N/A
- QTRX N/A
- EPS
- NMAI 0.64
- QTRX N/A
- Revenue
- NMAI N/A
- QTRX $125,784,000.00
- Revenue This Year
- NMAI N/A
- QTRX N/A
- Revenue Next Year
- NMAI N/A
- QTRX $37.89
- P/E Ratio
- NMAI $19.03
- QTRX N/A
- Revenue Growth
- NMAI N/A
- QTRX N/A
- 52 Week Low
- NMAI $10.60
- QTRX $4.05
- 52 Week High
- NMAI $12.55
- QTRX $15.86
- Technical
- Relative Strength Index (RSI)
- NMAI 52.17
- QTRX 60.47
- Support Level
- NMAI N/A
- QTRX $4.25
- Resistance Level
- NMAI $13.05
- QTRX $4.60
- Average True Range (ATR)
- NMAI 0.09
- QTRX 0.26
- MACD
- NMAI -0.45
- QTRX 0.12
- Stochastic Oscillator
- NMAI 99.00
- QTRX 88.03
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.